In several cancer types, including colorectal cancer (CRC), breast cancer, and non-small cell lung cancer (NSCLC), low levels of alkaline phosphatase (ALP) have been associated with a worse prognosis for patients [28]. This evidence concerns the gene ALPP and non-small cell lung carcinoma.